186 related articles for article (PubMed ID: 37750913)
1. Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?
Shalem T; Cohen DL; Epstein-Rigbi N; Elizur A; Eindor-Abarbanel A; Broide E; Richter V
Eur J Pediatr; 2023 Dec; 182(12):5409-5416. PubMed ID: 37750913
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences among eosinophilic esophagitis, proton-pump inhibitor-responsive esophageal eosinophilia, and reflux esophagitis: comparisons of clinical, endoscopic, and histopathological findings in Japanese patients.
Jiao D; Ishimura N; Maruyama R; Ishikawa N; Nagase M; Oshima N; Aimi M; Okimoto E; Mikami H; Izumi D; Okada M; Ishihara S; Kinoshita Y
J Gastroenterol; 2017 Feb; 52(2):203-210. PubMed ID: 27108416
[TBL] [Abstract][Full Text] [Related]
3. Ethical Implications of Continuing Oral Immunotherapy After the Development of Eosinophilic Esophagitis.
Wilson BE; Meltzer EC; Wright BL
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3638-3644. PubMed ID: 37572751
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
[TBL] [Abstract][Full Text] [Related]
5. Oral Immunotherapy and Risk of Eosinophilic Esophagitis in Children: 15 Years' Experience.
Morales-Cabeza C; Infante S; Cabrera-Freitag P; Fuentes-Aparicio V; Zubeldia JM; Álvarez-Perea A
J Pediatr Gastroenterol Nutr; 2023 Jan; 76(1):53-58. PubMed ID: 36190840
[TBL] [Abstract][Full Text] [Related]
6. Conservative long-term treatment of children with eosinophilic esophagitis.
Levine J; Lai J; Edelman M; Schuval SJ
Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice.
Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ;
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
[TBL] [Abstract][Full Text] [Related]
10. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
Moawad FJ; Schoepfer AM; Safroneeva E; Ally MR; Chen YJ; Maydonovitch CL; Wong RK
Aliment Pharmacol Ther; 2014 Mar; 39(6):603-8. PubMed ID: 24461332
[TBL] [Abstract][Full Text] [Related]
12. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center].
Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N
Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243
[TBL] [Abstract][Full Text] [Related]
13. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs.
Warners MJ; van Rhijn BD; Curvers WL; Smout AJ; Bredenoord AJ
Eur J Gastroenterol Hepatol; 2015 May; 27(5):506-11. PubMed ID: 25822858
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil-Derived Neurotoxin Predicts Response to Proton-Pump Inhibitor Treatment in Pediatric Eosinophilic Esophagitis.
Irastorza LE; Hopson P; Nabar S; Deb C; Smadi Y
J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):267-271. PubMed ID: 34321427
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
Frandsen LT; Westmark S; Melgaard D; Krarup AL
United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
[TBL] [Abstract][Full Text] [Related]
16. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis.
Thakkar KP; Fowler M; Keene S; Iuga A; Dellon ES
Dig Liver Dis; 2022 Sep; 54(9):1179-1185. PubMed ID: 35410852
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
Ishimura N; Kinoshita Y
J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
[TBL] [Abstract][Full Text] [Related]
19. Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis.
Kuzumoto T; Tanaka F; Sawada A; Nadatani Y; Otani K; Hosomi S; Kamata N; Taira K; Nagami Y; Tanigawa T; Watanabe T; Fujiwara Y
Esophagus; 2021 Apr; 18(2):372-379. PubMed ID: 32960382
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors.
Vieira GG; Ribeiro LBM; Truppel SK; Rosário Filho NA; Vieira MC
J Pediatr (Rio J); 2020; 96(5):638-643. PubMed ID: 31361987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
